New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Research team creates more effective lymphatic cancer therapy

Research team creates more effective lymphatic cancer therapy

byTohoku UniversityThe ex vivo bioluminescence intensity of the metastatic LN was lowest in the Single M-TBI + LDDS group, followed by the Single M-TBI group and the LDDS group, and all these gr
Oncology January 29,2024
Research team creates more effective lymphatic cancer therapy

Research team creates more effective lymphatic cancer therapy

byTohoku UniversityThe ex vivo bioluminescence intensity of the metastatic LN was lowest in the Single M-TBI + LDDS group, followed by the Single M-TBI group and the LDDS group, and all these gr
Oncology January 29,2024
New tools to manage rare eye cancer

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e
Oncology January 29,2024
New tools to manage rare eye cancer

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e
Oncology January 29,2024
Research finds unexpected link between chromosomal instability and epigenetic alterations

Research finds unexpected link between chromosomal instability and epigenetic alterations

by Ian Demsky,Memorial Sloan Kettering Cancer CenterThe two colored dots outside of this breast cancer cell's primary nucleus indicate the presence of micronuclei. A new study investigated h
Oncology January 29,2024
Research finds unexpected link between chromosomal instability and epigenetic alterations

Research finds unexpected link between chromosomal instability and epigenetic alterations

by Ian Demsky,Memorial Sloan Kettering Cancer CenterThe two colored dots outside of this breast cancer cell's primary nucleus indicate the presence of micronuclei. A new study investigated h
Oncology January 29,2024
Avoid unnecessary removal of lymph nodes in breast cancer, recommends new study

Avoid unnecessary removal of lymph nodes in breast cancer, recommends new study

by Universitätsklinikum HeidelbergRadiation planning CT after axillary lymph node dissection. The arrow shows the clips at the upper border of axillary dissection. No surgical changes are noted behind
Oncology January 29,2024
Avoid unnecessary removal of lymph nodes in breast cancer, recommends new study

Avoid unnecessary removal of lymph nodes in breast cancer, recommends new study

by Universitätsklinikum HeidelbergRadiation planning CT after axillary lymph node dissection. The arrow shows the clips at the upper border of axillary dissection. No surgical changes are noted behind
Oncology January 29,2024
In situ, invasive melanoma diagnoses decreased in 2020

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from
Oncology January 29,2024
In situ, invasive melanoma diagnoses decreased in 2020

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from
Oncology January 29,2024
A potential therapeutic vaccine strategy for a subset of myeloproliferative neoplasms

A potential therapeutic vaccine strategy for a subset of myeloproliferative neoplasms

by Ludwig Cancer ResearchCredit: CC0 Public DomainThe cells of a subset of myeloproliferative neoplasms (MPNs), slow-growing blood cancers, have frameshift mutations in their calreticulin (CALR)
Oncology January 29,2024
A potential therapeutic vaccine strategy for a subset of myeloproliferative neoplasms

A potential therapeutic vaccine strategy for a subset of myeloproliferative neoplasms

by Ludwig Cancer ResearchCredit: CC0 Public DomainThe cells of a subset of myeloproliferative neoplasms (MPNs), slow-growing blood cancers, have frameshift mutations in their calreticulin (CALR)
Oncology January 29,2024
Night work may increase the risk of aggressive prostate cancer in offshore petroleum workers

Night work may increase the risk of aggressive prostate cancer in offshore petroleum workers

by University of Oslo, Faculty of MedicineExposure-risk curve for a non-linear model of rollover shift work exposure, generated using restricted cubic splines with five knots (0.58, 3.82, 8.99, 14.98
Oncology January 29,2024
Night work may increase the risk of aggressive prostate cancer in offshore petroleum workers

Night work may increase the risk of aggressive prostate cancer in offshore petroleum workers

by University of Oslo, Faculty of MedicineExposure-risk curve for a non-linear model of rollover shift work exposure, generated using restricted cubic splines with five knots (0.58, 3.82, 8.99, 14.98
Oncology January 29,2024
Research reveals cancer-killing benefits of popular obesity treatment

Research reveals cancer-killing benefits of popular obesity treatment

by Maynooth UniversityCredit: CC0 Public DomainMaynooth University's Kathleen Londsdale Institute for Human Health Research has just published research into the benefits of the popular obesity tre
Oncology January 29,2024
Research reveals cancer-killing benefits of popular obesity treatment

Research reveals cancer-killing benefits of popular obesity treatment

by Maynooth UniversityCredit: CC0 Public DomainMaynooth University's Kathleen Londsdale Institute for Human Health Research has just published research into the benefits of the popular obesity tre
Oncology January 29,2024
Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types

Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple c
Oncology January 29,2024
Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types

Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple c
Oncology January 29,2024
Study shows benefit of universal genetic testing after breast cancer diagnosis

Study shows benefit of universal genetic testing after breast cancer diagnosis

byWalter and Eliza Hall Institute of Medical ResearchClassification of 31 participants found to carry pathogenic gene variants, by gene, estimated risk of having a pathogenic gene variant,* and
Oncology January 29,2024
Study shows benefit of universal genetic testing after breast cancer diagnosis

Study shows benefit of universal genetic testing after breast cancer diagnosis

byWalter and Eliza Hall Institute of Medical ResearchClassification of 31 participants found to carry pathogenic gene variants, by gene, estimated risk of having a pathogenic gene variant,* and
Oncology January 29,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com